Is it time to redefine the management of febrile neutropenia in cancer patients?
- 1 March 1995
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (3) , 221-223
- https://doi.org/10.1016/s0002-9343(99)80366-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Physicians, pharmacists, and home infusion antibiotic therapyThe American Journal of Medicine, 1994
- Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropeniaCancer, 1994
- Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.Journal of Clinical Oncology, 1994
- Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancerCancer, 1993
- Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospitalThe Journal of Pediatrics, 1992
- Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.Journal of Clinical Oncology, 1992
- Short Courses of Antibiotics in Selected Febrile Neutropenic PatientsThe Lancet Healthy Longevity, 1991
- Home treatment of febrile neutropenia: An empirical oral antibiotic regimenAnnals of Oncology, 1991
- Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.Journal of Clinical Oncology, 1990
- The Medical Course of Cancer Patients With Fever and NeutropeniaArchives of internal medicine (1960), 1988